Xnap-8 [Acetyl Octapeptide-3, Snap8 – 30mg] – 3 Vials – Corey Pauling

Laboratory: Corey Pauling
Form: Subcutaneous injection
Molecule: Acetyl Octapeptide-3 (SNAP-8)
Concentration: 10mg/vial
Volume: 3 vials
Xnap-8 [10mg] contains Acetyl Octapeptide-3 (SNAP-8), a synthetic octapeptide that modulates the SNARE pathway involved in neurotransmitter release and facial muscle contraction. It is studied for its potential to reduce expression lines, fine wrinkles, and signs of skin aging.

Description and Effects

XNAP-8 [Acetyl Octapeptide-3 10mg] contains SNAP-8 (Acetyl Octapeptide-3), a synthetic octapeptide derived from the N-terminal end of SNAP-25. SNAP-8 is designed to modulate the SNARE complex involved in neurotransmitter release and facial muscle contraction. By influencing this pathway, it may promote subtle relaxation of facial muscles and help reduce the appearance of dynamic expression lines and wrinkles.

Product Benefits

• Expression Line Reduction: Studied for its potential to reduce the visible appearance of dynamic wrinkles caused by repetitive facial movements.
• Skin Smoothing: May contribute to a smoother and more relaxed appearance of the skin.
• Anti-Aging Support: Studied for its potential role in reducing fine lines and visible signs of skin aging.
• SNARE Complex Modulation: Influences a molecular pathway involved in neurotransmitter release and muscle contraction.

Usage Guidelines

• Research Protocol: Subcutaneous protocol ranging from 330 to 1,000mcg once daily, with gradual titration over 8 to 12 weeks.
• Titration: The referenced protocol uses 330mcg daily during weeks 1–4, 500mcg daily during weeks 5–8, and up to 1,000mcg daily during weeks 9–12.
• Method of Administration: Administered by subcutaneous injection according to the research protocol.

Precautions and Wellness

• Possible Side Effects: Possible reactions may include temporary irritation, redness, itching, sensitivity, or discomfort at the injection site.
• Injection Safety: Use appropriate sterile technique and proper injection procedures when handling and administering injectable preparations.
• Monitoring: Monitor injection-site reactions, general tolerance, and any unusual effects during use.
• Storage: Store the lyophilized peptide in a cool, dry place. After reconstitution, refrigerate according to the manufacturer's storage instructions.